# Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

> **NCT02991235** · NA · UNKNOWN · sponsor: **Bioiberica** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** PRJ212
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02991235
- **Lead sponsor:** Bioiberica
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02991235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02991235, "Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02991235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*